|
|
Blood, 15 April 2008, Vol. 111, No. 8, pp. 4245-4253.
Prepublished online as a Blood First Edition Paper on February 7, 2008; DOI 10.1182/blood-2007-03-081398.
Previous Article | Next Article 
Submitted March 21, 2007
Accepted January 31, 2008
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN- production
Friederike Meyer-Wentrup, Daniel Benitez-Ribas, Paul J. Tacken, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries, and Gosse J. Adema*
Department of Tumor Immunology, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, Netherlands
Department of Medical Oncology, Radboud University Nijmegen Medical Centre and Nijmegen Centre for Molecular Life Sciences, Nijmegen, Netherlands
* Corresponding author; email: g.adema{at}ncmls.ru.nl.
C-type lectin receptors (CLRs) fulfill multiple functions within the immune system by recognition of carbohydrate moieties on foreign or (altered) self structures. CLRs on myeloid dendritic cells (DCs) have been well characterized as pattern-recognition receptors (PRRs) combining ligand internalization with complex signaling events. Much less is known about CLR expression and function in human plasmacytoid DCs (pDCs), the major type I IFN producers. In this study, we demonstrate that next to the CLR BDCA-2, human pDCs express DCIR, a CLR with putative immune-inhibitory function, but not dectin-1, mannose receptor or DC-SIGN. DCIR surface levels are reduced upon pDC maturation following TLR9 triggering. Interestingly, DCIR triggering inhibits TLR9-induced IFN- production, while leaving upregulation of co-stimulatory molecule expression unaffected. Furthermore, DCIR is readily internalized into pDCs after receptor triggering. We show that DCIR internalization is clathrin-dependent as it can be inhibited by hypertonic shock and dominant-negative dynamin. Importantly, antigens targeted to pDCs via DCIR are presented to T cells. These findings indicate that targeting DCIR on pDCs not only results in efficient antigen presentation but also affects TLR9-induced IFN- production. Collectively, the data show that targeting of DCIR can modulate human pDC function and may be applied in disease prevention and treatment.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Flores, D. D. Desai, M. Downie, B. Liang, M. P. Reilly, S. E. McKenzie, and R. Clynes
Dominant Expression of the Inhibitory Fc{gamma}RIIB Prevents Antigen Presentation by Murine Plasmacytoid Dendritic Cells
J. Immunol.,
December 1, 2009;
183(11):
7129 - 7139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Angelot, E. Seilles, S. Biichle, Y. Berda, B. Gaugler, J. Plumas, L. Chaperot, F. Dignat-George, P. Tiberghien, P. Saas, et al.
Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases
Haematologica,
November 1, 2009;
94(11):
1502 - 1512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Kaden, S. Kurig, K. Vasters, K. Hofmann, K. S. Zaenker, J. Schmitz, and G. Winkels
Enhanced Dendritic Cell-Induced Immune Responses Mediated by the Novel C-Type Lectin Receptor mDCAR1
J. Immunol.,
October 15, 2009;
183(8):
5069 - 5078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cermelli, C. F. Orsi, A. Cuoghi, A. Ardizzoni, E. Tagliafico, R. Neglia, S. Peppoloni, and E. Blasi
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences
J. Med. Microbiol.,
October 1, 2009;
58(10):
1283 - 1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Sadaka, M.-A. Marloie-Provost, V. Soumelis, and P. Benaroch
Developmental regulation of MHC II expression and transport in human plasmacytoid-derived dendritic cells
Blood,
March 5, 2009;
113(10):
2127 - 2135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Meyer-Wentrup, A. Cambi, B. Joosten, M. W. Looman, I. J. M. de Vries, C. G. Figdor, and G. J. Adema
DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production
J. Leukoc. Biol.,
March 1, 2009;
85(3):
518 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. De Filippo, R. J. Binder, C. Camisaschi, V. Beretta, F. Arienti, A. Villa, P. Della Mina, G. Parmiani, L. Rivoltini, and C. Castelli
Human Plasmacytoid Dendritic Cells Interact with gp96 via CD91 and Regulate Inflammatory Responses
J. Immunol.,
November 1, 2008;
181(9):
6525 - 6535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Benitez-Ribas, P. Tacken, C. J. A. Punt, I. J. M. de Vries, and C. G. Figdor
Activation of Human Plasmacytoid Dendritic Cells by TLR9 Impairs Fc{gamma}RII-Mediated Uptake of Immune Complexes and Presentation by MHC Class II
J. Immunol.,
October 15, 2008;
181(8):
5219 - 5224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Lambert, C. Gilbert, M. Richard, A. D. Beaulieu, and M. J. Tremblay
The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways
Blood,
August 15, 2008;
112(4):
1299 - 1307.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|